Kyrgyzstan vs Tajikistan: The number of people with susceptibility test result for rifampicin
Kyrgyzstan
1,932
in 2021
Tajikistan
1,862
in 2021
Kyrgyzstan rank
49th
Tajikistan rank
50th
The number of people with susceptibility test result for rifampicin over time
- Kyrgyzstan
- Tajikistan
How they compare
Kyrgyzstan currently reports 1,932 against 1,862 in Tajikistan, a difference of 70.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Tajikistan ahead.
Kyrgyzstan ranks 49th and Tajikistan ranks 50th of 155 countries.
Across the 2 decades both report, Kyrgyzstan averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Kyrgyzstan | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,316 | 2,412 | 96.33 | Tajikistan |
| 2020s | 1,836 | 1,772 | 64 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kyrgyzstan or Tajikistan?
- Kyrgyzstan, at 1,932 against 1,862 in Tajikistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kyrgyzstan and Tajikistan?
- 70, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Tajikistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Kyrgyzstan and Tajikistan rank globally for the number of people with susceptibility test result for rifampicin?
- Kyrgyzstan ranks 49th and Tajikistan ranks 50th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.